Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Glen Tullman
AI and Machine Learning
CES 2024: Mark Cuban on AI's impact on healthcare
Mark Cuban and Transcarent CEO Glen Tullman shared the stage at CES to talk AI, price transparency and the future of healthcare.
Heather Landi
Jan 11, 2024 7:00pm
Transcarent to acquire part of virtual care company 98point6
Mar 6, 2023 11:15am
Tullman's firm banks on virtual diabetes clinic with $16M round
Apr 14, 2022 7:14am
Tullman's Transcarent confirms $1.6B valuation with $200M round
Jan 11, 2022 3:30pm